Douglas Iddings, DO
Surgical Oncology · Flint, MINPI 1023233384
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by TELA Bio, Inc. at 25.1% of the total. Among surgical oncology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $58.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$2K
- Checkpoint Surgical, Inc$2K
- Histosonics, Inc.$1K
- Medical Device Business Services, Inc.$997
- AbbVie$236
- Covidien LP$224
- plus $1K from 18 others
What the payments were for
- Consulting fees$1,50020%
- Travel & lodging$2,93039%
- Food & beverage$3,04341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 15 | $1,878 |
| Checkpoint Surgical, Inc | 5 | $1,655 |
| Histosonics, Inc. | 2 | $1,182 |
| Medical Device Business Services, Inc. | 6 | $997 |
| AbbVie(2 entities) | 13 | $236 |
| Covidien LP | 21 | $224 |
| Nestle Healthcare Nutrition Inc. | 13 | $224 |
| Johnson & Johnson | 14 | $216 |
| Medtronic | 3 | $159 |
| Endo Pharmaceuticals Inc. | 9 | $145 |
| Smith+Nephew | 5 | $145 |
| Organogenesis Inc. | 3 | $71 |
| Davol Inc. | 3 | $56 |
| Angiodynamics, Inc. | 2 | $53 |
| Integra Lifesciences Corporation | 2 | $39 |
| Innocoll Pharmaceuticals Limited | 2 | $36 |
| Elucent Medical | 1 | $31 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Solventum Corporation | 1 | $21 |
| Acell, Inc. | 1 | $20 |
| Intuitive Surgical | 2 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
| Fortovia Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,473 in reported general payments places this provider in the 95th percentile of 28 surgical oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $12,450 |
| JardianceEmpagliflozin | 14 | $6,477 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 21 | $1,288 |
| Quetiapine Fumarate | 23 | $1,254 |
| Midodrine Hcl | 15 | $1,101 |
| Levothyroxine Sodium | 117 | $960 |
| Scopolamine | 13 | $763 |
| Tamsulosin Hcl | 28 | $471 |
| Pantoprazole Sodium | 45 | $426 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $414 |
| Methenamine Hippurate | 16 | $308 |
| Atorvastatin Calcium | 33 | $276 |
| Trazodone Hcl | 22 | $236 |
| Olanzapine | 26 | $201 |
| Amlodipine Besylate | 20 | $173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $16 | $20126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 28 surgical oncology providers in Michigan.
Other surgical oncology in Flint
- Sukamal SahaFlint$3K
- Gitonga MuneneKalamazoo$82K
- John BarnwellDetroit$7K
- Tong QuEast Lansing$7K
- Rupen ShahDetroit$4K
- Srinivas KavuturuEast Lansing$4K
- Elizabeth PaulusSaginaw$4K
- Mathew ChungGrand Rapids$2K
- Lindsay PetersenDetroit$2K
- Lauren PerryAnn Arbor$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.